- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Astellas Pharma Canada, Inc.
Total 1236 results
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedSafety of ASP2151United States
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Astellas Pharma IncCompletedCoronary Artery Disease | Pulmonary Disease, Chronic Obstructive | AsthmaUnited States
-
Astellas Pharma IncCompletedChronic Plaque PsoriasisUnited States, Canada
-
Astellas Pharma IncCompletedAtrial FibrillationTaiwan, Japan, Korea, Republic of, New Zealand, Singapore, South Africa, Thailand, Australia, Hong Kong, Malaysia
-
Astellas Pharma IncCompletedHealthy Subjects | Bioavailability of ASP015K | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompletedRenal TransplantationUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941 | Pharmacokinetics of MitiglinideJapan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedSleep Initiation and Maintenance Disorders | Primary InsomniaTaiwan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy Subjects | Drug Interactions | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompletedErectile Dysfunction | Prostate CancerUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP015K and TacrolimusUnited States
-
Astellas Pharma IncCompletedHealthy VolunteersJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan, Korea, Republic of, Taiwan, Thailand
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin SuccinateUnited States
-
Astellas Pharma IncCompletedRenal Insufficiency, Chronic | Kidney Failure, Chronic | Kidney TransplantationRussian Federation
-
Astellas Pharma IncCompletedDiabetes Mellitus Type 2Russian Federation
-
Astellas Pharma IncCompletedKidney Transplantation | Graft RejectionUnited States
-
Astellas Pharma IncCompletedBone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host DiseaseJapan
-
Astellas Pharma Europe Ltd.Completed
-
Astellas Pharma Europe B.V.CompletedUnderactive BladderJapan, Poland, Germany, Netherlands, Slovakia, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCzechia, France, Italy, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases | Urological Manifestations | Signs and SymptomsBelarus, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
Astellas Pharma a/sCompletedChronic Kidney Disease Associated AnemiaSweden
-
Astellas Pharma Europe Ltd.TerminatedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
-
Astellas Pharma Europe B.V.CompletedPain | Urologic Diseases | Cystitis, Interstitial | Urinary Bladder DiseaseBelgium, Czechia, Denmark, Germany, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Russian Federation, Spain
-
Astellas Pharma Europe Ltd.CompletedLiver Transplant | Kidney TransplantItaly, Spain, Belgium, Germany, Latvia, Canada, Korea, Republic of, Czechia, Austria, Finland, Belarus, Estonia, France, Hungary, Ireland, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Sweden, Switzerland, United...
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney TransplantationFrance, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedInflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma Europe Ltd.Terminated
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveCzech Republic
-
Astellas Pharma Europe B.V.CompletedChronic Lymphocytic LeukemiaRussian Federation